TransCode Therapeutics In... (RNAZ)
NASDAQ: RNAZ
· Real-Time Price · USD
10.97
-0.08 (-0.72%)
At close: Aug 15, 2025, 3:59 PM
10.73
-2.19%
After-hours: Aug 15, 2025, 05:33 PM EDT
TransCode Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 753.15K | 753.15K | 753.15K | 753.15K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | 140.17K | 278.96K | 416.55K | 516.75K | 406.08K | 267.3K | 152.4K | 73.8K | 73.29K | 80.82K | 62.82K | 42.47K | 13.48K | 5.95K | 1.25K |
Gross Profit | n/a | n/a | 612.97K | 474.19K | 336.6K | 236.4K | -406.08K | -267.3K | -152.4K | -73.8K | -73.29K | -80.82K | -62.82K | -42.47K | -13.48K | -5.95K | -1.25K |
Operating Income | -15.54M | -15.66M | -14.63M | -17.79M | -17.81M | -19.42M | -20.89M | -20.51M | -20.09M | -18.67M | -16.12M | -13.53M | -9.18M | -6.15M | -3.54M | -1.42M | -1.16M |
Interest Income | 662.00 | 684.00 | 662.00 | 614.00 | 682.00 | 5.28K | 14.78K | 23.65K | 24.74K | 20.41K | 11.28K | 2.42K | 1.09K | 663.00 | 175.00 | 62.00 | 119.00 |
Pretax Income | -25.51M | -16.75M | -14.93M | -17.91M | -17.06M | -18.55M | -19.59M | -18.58M | -18.91M | -17.56M | -18.34M | -16.38M | -8.94M | -9.95M | -4.85M | -3.89M | -6.79M |
Net Income | -25.51M | -16.75M | -14.93M | -17.91M | -17.06M | -18.54M | -32.86M | -31.85M | -32.15M | -30.8M | -21.22M | -19.23M | -8.7M | -9.72M | -1.69M | -763.44K | -6.79M |
Selling & General & Admin | 5.38M | 5.95M | 5.2M | 6.24M | 6.38M | 7.15M | 9.3M | 9.22M | 9.15M | 8.43M | 7.29M | 6.75M | 4.81M | 3.4M | 1.92M | 742.22K | 615.04K |
Research & Development | 10.17M | 9.71M | 9.43M | 11.55M | 11.43M | 12.26M | 11.59M | 11.29M | 10.94M | 10.23M | 9.04M | 6.99M | 4.58M | 2.96M | 1.62M | 681.27K | 544.52K |
Other Expenses | n/a | n/a | 79.41K | 79.41K | 79.41K | n/a | -463.18K | -463.18K | -497.91K | -425.49K | 47.07K | 15.33K | -6.99K | n/a | -88.79K | -57.05K | n/a |
Operating Expenses | 15.54M | 15.66M | 14.49M | 17.62M | 16.85M | 18.38M | 19.61M | 18.61M | 18.94M | 17.59M | 15.73M | 13.76M | 9.38M | 6.36M | 3.46M | 1.37M | 1.16M |
Interest Expense | 17.22K | 26.81K | 80.88K | 70.09K | 73.45K | 77.17K | 21.27K | 21.27K | 13.43K | n/a | n/a | 333.00 | 42.3K | 95.07K | 148.93K | 428.88K | 422.56K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 15.54M | 15.66M | 14.63M | 17.76M | 16.99M | 18.52M | 19.61M | 18.61M | 18.94M | 17.59M | 15.24M | 13.27M | 8.89M | 5.87M | 3.46M | 1.37M | 1.16M |
Income Tax Expense | n/a | n/a | -3 | 27.44K | 27.44K | 22.67K | 13.3M | 13.27M | 13.23M | 13.23M | 2.88M | 2.85M | -240.01K | -232.57K | -3.16M | -3.13M | -57 |
Shares Outstanding (Basic) | 172.26K | 356.12K | 356.12K | 213.67K | 155.83K | 5.37K | 109.41K | 30.49K | 18.59K | 486.66 | 16.22K | 16.22K | 16.22K | 480.00 | 14.41K | 14.96K | 14.95K |
Shares Outstanding (Diluted) | 172.26K | 356.12K | 356.12K | 213.67K | 155.83K | 5.37K | 109.41K | 30.49K | 18.59K | 486.66 | 16.22K | 16.22K | 16.22K | 483.90 | 14.41K | 14.96K | 14.95K |
EPS (Basic) | -95.97 | -47.14 | -791.69 | -855.47 | -973.43 | -1.21K | -38.28K | -38.49K | -38.64K | -38.6K | -19.17K | -19.07K | -18.6K | -18.68K | -3.62K | -3.64K | -3.84K |
EPS (Diluted) | -95.97 | -47.14 | -791.69 | -855.47 | -973.43 | -1.21K | -38.28K | -38.49K | -38.64K | -38.6K | -19.02K | -18.92K | -18.45K | -18.53K | -3.62K | -3.64K | -3.84K |
EBITDA | -25.05M | -16.19M | -14.29M | -17.27M | -16.43M | -17.97M | -19.19M | -18.29M | -18.73M | -17.47M | -15.13M | -13.19M | -5.72M | -6.71M | -4.31M | -3.09M | -6M |
EBIT | -25.5M | -16.73M | -14.84M | -17.83M | -16.98M | -18.46M | -19.57M | -18.57M | -18.91M | -17.57M | -15.24M | -13.27M | -5.79M | -6.75M | -4.7M | -3.46M | -6.37M |
Depreciation & Amortization | 444.38K | 534.86K | 552.17K | 563.44K | 558.19K | 516.75K | 406.08K | 292.1K | 177.2K | 98.61K | 98.09K | 80.82K | 62.82K | 42.47K | 392.48K | 624.44K | 711.35K |